Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DAVILA

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Journal for Immunotherapy of Cancer|July 26, 2022
Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapyNada S Aboelella, Caitlin Brandle, Ogacheko Okoko, et al.
Molecular Therapy Oncolytics|December 11, 2023
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemiaJustin C Boucher, Bishwas Shrestha, Paresh Vishwasrao, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicitiesPayal Goala, Yongliang Zhang, Cooper Sailer, et al.
Transplantation and Cellular Therapy|March 6, 2023
Outcomes of CD19-Directed Chimeric Antigen Receptor T Cell Therapy for Transformed Nonfollicular LymphomaNing Dong, Lucía Rubio Lopes-Garcia, David Viñal, et al.
The Journal of Clinical Investigation|May 22, 2020
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host diseaseBishwas Shrestha, Kelly Walton, Jordan Reff, et al.
Cancer Immunology Research|November 14, 2020
CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell FunctionJustin C Boucher, Gongbo Li, Hiroshi Kotani, et al.
Blood|April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphomaMichael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
BMJ Open|November 15, 2017
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour typesCaroline Lonez, Bikash Verma, Alain Hendlisz, et al.
Blood|April 14, 2021
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapyKitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Cre-dependent gene expression enables thymic development of autoreactive tumor-associated antigen targeting CAR-T cellsManpreet Bariana, Michael McGuire, Andrea Tuckett, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|July 26, 2022
Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapyNada S Aboelella, Caitlin Brandle, Ogacheko Okoko, et al.
Molecular Therapy Oncolytics|December 11, 2023
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemiaJustin C Boucher, Bishwas Shrestha, Paresh Vishwasrao, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicitiesPayal Goala, Yongliang Zhang, Cooper Sailer, et al.
Transplantation and Cellular Therapy|March 6, 2023
Outcomes of CD19-Directed Chimeric Antigen Receptor T Cell Therapy for Transformed Nonfollicular LymphomaNing Dong, Lucía Rubio Lopes-Garcia, David Viñal, et al.
The Journal of Clinical Investigation|May 22, 2020
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host diseaseBishwas Shrestha, Kelly Walton, Jordan Reff, et al.
Cancer Immunology Research|November 14, 2020
CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell FunctionJustin C Boucher, Gongbo Li, Hiroshi Kotani, et al.
Blood|April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphomaMichael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
BMJ Open|November 15, 2017
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour typesCaroline Lonez, Bikash Verma, Alain Hendlisz, et al.
Blood|April 14, 2021
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapyKitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Cre-dependent gene expression enables thymic development of autoreactive tumor-associated antigen targeting CAR-T cellsManpreet Bariana, Michael McGuire, Andrea Tuckett, et al.
Pageof 10